EDMONTON, April 28 /CNW/ - (TSX:ISA) - Isotechnika Inc. announced today
that collaborators with Lux Biosciences, Inc. are scheduled to present data on
the use of voclosporin with Lux's proprietary topical and new bioerodible
polymer/drug products for the treatment of dry eye and other inflammatory eye
diseases. These multiple presentations (poster and oral) will take place at
the Association for Research in Vision and Ophthalmology (ARVO) conference
scheduled from April 27 - May 1 in Fort Lauderdale, Florida.
